PRRT in patients with neuroendocrine tumor: preliminary results of OAR dosimetry and dose-response relationship for NET hepatic metastases. (December 2021) - Tonini, E.; Panareo, S.; Longo, M.; Longo, L.; Urso, L.; Caracciolo, M.; Uccelli, L.; Cittanti, C.; Turra, A.; Bartolomei, M.